Reports

12671 Results (Page 499 of 507)

All Market Research Reports

Medical Devices

Vietnam Dental Endodontics Market Analysis

Vietnam Dental Endodontics Market was valued at $8.80 Mn in 2023 and is predicted to grow at a CAGR of 4.53% from 2023 to 2030, to $11.90 Mn by 2030. The key drivers of this industry include increasing awareness of oral health, the rising prevalence of dental problems, and growing dental infrastructure. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Pharmaceuticals

US Bone Disease Therapeutics Market

US Bone Disease Therapeutics Market valued at $6.804 Bn in 2022, projected to reach $11.603 Mn by 2030 with a 6.9% CAGR. The key drivers of this industry include the increasing aging population of the US, technological advancements, supportive economic conditions, and others. The industry is primarily dominated by players such as Amgen, Pfizer, Merck, Eli Lilly, Novartis, Bayer, and Johnson & Johnson, among others.

PUBLISHED: Apr, 2024 | FORMAT: PPT | LAST UPDATED: Apr, 2024 | PRICE: $3999

Pharmaceuticals

China Clinical Nutrition Market Analysis

The China Clinical Nutrition Market was valued at $2465.5 Mn in 2023 and is projected to grow at a CAGR of 6.84% from 2023 to 2023, to $3917.8 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as CSPC Pharmaceuticals Group, Fancl Corporation, Health Food Company, Amway, Pfizer, Bayer among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Medical Devices

Egypt Dental Endodontics Market Analysis

Egypt Dental Endodontics Market was valued at $4.90 Mn in 2023 and is predicted to grow at a CAGR of 5.8% from 2023 to 2030, to $7.30 Mn by 2030. The key drivers of this industry include increasing awareness of oral health, the rising prevalence of dental problems, and growing dental infrastructure. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Pharmaceuticals

Vietnam Cancer Induced Bone Disease Therapeutics Market

Vietnam Cancer Induced Bone Disease Therapeutics Market valued at $7 Mn in 2022, projected to reach $10 Mn by 2030 with a 6.03% CAGR. The key drivers of this industry include the rising incidence of cancer, the expanding treatment landscape, and increased government initiatives. The industry is primarily dominated by players such as Bristol Myers Squibb, AstraZeneca, Merck, Eli Lilly, Pfizer, Johnson & Johnson, Amgen, and Novartis among others.

PUBLISHED: Apr, 2024 | FORMAT: PPT | LAST UPDATED: Apr, 2024 | PRICE: $3999

Pharmaceuticals

Indonesia Clinical Nutrition Market Analysis

The Indonesia Clinical Nutrition Market was valued at $184 Mn in 2023 and is projected to grow at a CAGR of 5.34% from 2023 to 2023, to $264.9 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Nature’s Sunshine Products, Darya-Varia Laboratoria Tbk, Bio Farma and Citra Nusa Insan Cemerlang.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Medical Devices

Kenya Dental Endodontics Market Analysis

Kenya Dental Endodontics Market was valued at $1.20 Mn in 2023 and is predicted to grow at a CAGR of 5.4% from 2023 to 2030, to $1.80 Mn by 2030. The key drivers of this industry include increasing awareness of oral health, development of medical tourism, and growing dental infrastructure. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Pharmaceuticals

US Cancer Induced Bone Disease Therapeutics Market

US Cancer Induced Bone Disease Therapeutics Market valued at $546 Mn in 2022, projected to reach $736 Mn by 2030 with a 3.8% CAGR. The key drivers of this industry include an upward trend in the incidence of cancer, an expanding therapeutic landscape, treatment advancements, and others. The industry is primarily dominated by players such as Amgen, Pfizer, Merck, Medtronic, Novartis, Fresenius, and Johnson & Johnson, among others.

PUBLISHED: Apr, 2024 | FORMAT: PPT | LAST UPDATED: Apr, 2024 | PRICE: $3999

Pharmaceuticals

Japan Clinical Nutrition Market Analysis

The Japan Clinical Nutrition Market was valued at $1906.4 Mn in 2023 and is projected to grow at a CAGR of 5.84% from 2023 to 2023, to $2836.4 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Otsuka Pharmaceutical, Taisho Pharmaceutical, Kikkoman Corporation, and Ajinomoto, Abbott Nutrition, Nestle, Mead Johnson & Company, LLC among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Medical Devices

South Africa Dental Endodontics Market Analysis

South Africa Dental Endodontics Market was valued at $11.40 Mn in 2023 and is predicted to grow at a CAGR of 5.53% from 2023 to 2030, to $16.60 Mn by 2030. The key drivers of this industry include rising awareness of oral health, a growing geriatric population, and technological advancements. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Pharmaceuticals

Singapore Cancer Induced Bone Disease Therapeutics Market

Singapore Cancer Induced Bone Disease Therapeutics Market valued at $2 Mn in 2022, projected to reach $3 Mn by 2030 with a 6.4% CAGR. The key drivers of this industry include the rising incidence of cancer, technological advancements, and increased government funding. The industry is primarily dominated by players such as Radius Health, Bayer, Merck, Eli Lilly, Teva, Johnson & Johnson, Amgen, and Novartis among others.

PUBLISHED: Apr, 2024 | FORMAT: PPT | LAST UPDATED: Apr, 2024 | PRICE: $3999

Pharmaceuticals

Malaysia Clinical Nutrition Market Analysis

The Malaysia Clinical Nutrition Market was valued at $49.3 Mn in 2023 and is projected to grow at a CAGR of 5.54% from 2023 to 2023, to $71.9 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Bioalpha, Yakult, Abbott Nutrition, Pfizer Inc, Bayer AG, Nestle, Baxter International Inc., Otsuka Holdings Co., Ltd, Mead Johnson & Company, LLC among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Medical Devices

India Dental Endodontics Market Analysis

India Dental Endodontics Market was valued at $31.80 Mn in 2023 and is predicted to grow at a CAGR of 7.3% from 2023 to 2030, to $52.10 Mn by 2030. The key drivers of this industry include rising awareness of oral health, rising prevalence of dental problems, and technological advancements. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Pharmaceuticals

Spain Cancer Induced Bone Disease Therapeutics Market

Spain Cancer Induced Bone Disease Therapeutics Market valued at $25 Mn in 2022, projected to reach $37 Mn by 2030 with a 4.8% CAGR. The key drivers of this industry include the increase in the incidence of cancers, unmet medical needs, and technological advancements. The industry is primarily dominated by players such as Advaxis, Takeda, Gradalis, Roche, Eli Lilly, Hikma, Bayer, and Amgen among others.

PUBLISHED: Apr, 2024 | FORMAT: PPT | LAST UPDATED: Apr, 2024 | PRICE: $3999

Pharmaceuticals

Philippines Clinical Nutrition Market Analysis

The Philippines Clinical Nutrition Market was valued at $67.5 Mn in 2023 and is projected to grow at a CAGR of 5.84% from 2023 to 2023, to $100.4 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Vitacare, BioEssence, United Laboratories, USANA Health Sciences, Mead Johnson & Company, LLC among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Digital Health

Canada Digital Biomarkers Market Analysis

Canada Digital Biomarkers Market was valued at $232 Mn in 2023 and is predicted to grow at a CAGR of 22.3% from 2023 to 2030, to $949.45 Mn by 2030. The key drivers of this industry include advancements in technology, the growing prevalence of chronic diseases, rising healthcare costs, and increasing consumer health awareness. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Cancer Induced Bone Disease Therapeutics Market

Saudi Arabia Cancer Induced Bone Disease Therapeutics Market valued at $22 Mn in 2022, projected to reach $39 Mn by 2030 with a 7.3% CAGR. The key drivers of this industry include the rising incidence of cancer, the expanding therapeutic landscape, supportive government initiatives, and others. The industry is primarily dominated by players such as Amgen, Julphar, Novartis, Janssen, Sanofi, Roche, and Celgene among others.

PUBLISHED: Apr, 2024 | FORMAT: PPT | LAST UPDATED: Apr, 2024 | PRICE: $3999

Pharmaceuticals

Singapore Clinical Nutrition Market Analysis

The Singapore Clinical Nutrition Market was valued at $36.8 Mn in 2023 and is projected to grow at a CAGR of 5.94% from 2023 to 2023, to $55.1 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as iX Biopharma, NTUC Health, Baxter, Abbott Nutrition, Pfizer Inc, Nestle, Baxter International Inc. among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Digital Health

US Digital Biomarkers Market Analysis

US Digital Biomarkers Market was valued at $1,218 Mn in 2023 and is predicted to grow at a CAGR of 20.3% from 2023 to 2030, to $4,441.26 Mn by 2030. The key drivers of this industry include advancements in technology, the growing prevalence of chronic diseases, rising healthcare costs, and patient empowerment and engagement. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Pharmaceuticals

UK Cancer Induced Bone Diseases Therapeutics Market

UK Cancer Induced Bone Disease Therapeutics Market valued at $34 Mn in 2022, projected to reach $46 Mn by 2030 with a 3.8% CAGR. The key drivers of this industry include the rising incidence of cancers, a favorable regulatory environment, and technological advancements. The industry is primarily dominated by players such as Advaxis, Takeda, Gradalis, Johnson & Johnson, Hikma, Cellectar, and Amgen among others.

PUBLISHED: Apr, 2024 | FORMAT: PPT | LAST UPDATED: Apr, 2024 | PRICE: $3999

Pharmaceuticals

Vietnam Clinical Nutrition Market Analysis

The Vietnam Clinical Nutrition Market was valued at $153.3 Mn in 2023 and is projected to grow at a CAGR of 5.57% from 2023 to 2023, to $224.1 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Danone Nutrition, Abbott Nutrition, Pfizer Inc, Bayer AG, Nestle, Baxter International Inc Ltd, Mead Johnson & Company, LLC among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Digital Health

Saudi Arabia Digital Biomarkers Market Analysis

Saudi Arabia Digital Biomarkers Market was valued at $49.30 Mn in 2023 and is predicted to grow at a CAGR of 23.8% from 2023 to 2030, to $219.73 Mn by 2030. The key drivers of this industry include advancements in technology, the growing prevalence of chronic diseases, rising healthcare costs, and government initiatives. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Pharmaceuticals

Philippines Cancer Induced Bone Diseases Therapeutics Market

Philippines Cancer Induced Bone Disease Therapeutics Market valued at $3 Mn in 2022, projected to reach $5 Mn by 2030 with a 6.3% CAGR. The key drivers of this industry include increasing cancer incidence, expanding healthcare infrastructure, and government initiatives. The industry is primarily dominated by players such as Pharex Healthcare, Bayer, Merck, UniLab, TGP Group, Pascual Laboratories, Amgen, and Novartis among others.

PUBLISHED: Apr, 2024 | FORMAT: PPT | LAST UPDATED: Apr, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Clinical Nutrition Market Analysis

The Egypt Clinical Nutrition Market was valued at $85.9 Mn in 2023 and is projected to grow at a CAGR of 6.84% from 2023 to 2023, to $136.5 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Bio Pharma, Eva Pharma, Bio Pure, SEDICO, Abbott Nutrition, Mead Johnson & Company, LLC among others

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Digital Health

UAE Digital Biomarkers Market Analysis

UAE Digital Biomarkers Market was valued at $14.50 Mn in 2023 and is predicted to grow at a CAGR of 23.3% from 2023 to 2030, to $62.82 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, government initiatives, increased tech adoption, and focus on preventative care. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

subscribe to our newsletter
up